133 bp from the first exon of DopEcR were deleted and replaced with GAL4 by ends-out gene targeting.
DopEcRGAL4 drives expression in elav positive neurons in prominent neuropil structures and the mushroom bodies.
DopEcRc02142 homozygous and (to a lesser extent) heterozygous as well as DopEcRc02142/DopEcRGAL4 transheterozygous adults show resistance to ethanol-induced sedation: it takes significantly longer for them to become fully sedated compared to controls, although they begin to lose posture around the same time as controls, their ethanol absorption and metabolism is also normal. However, once sedated, significantly fewer DopEcRc02142 mutants survive and recover from sedation.
DopEcRGAL4 has chemical resistant | adult stage phenotype, suppressible | partially by EgfrKK100051/Scer\GAL4DopEcR-GAL4
DopEcRGAL4 has chemical resistant | adult stage phenotype, suppressible | partially by Dop1R1PL00420
DopEcRGAL4 has chemical resistant | adult stage phenotype, non-suppressible by DATfmn
DopEcRGAL4/DopEcRGAL4 is a suppressor of chemical sensitive | adult stage | temperature conditional phenotype of mldDTS3-1
The increased resistance to ethanol-induced sedation characteristic for DopEcRGAL4 homozygous adults is strongly suppressed by expression of EgfrKK100051 driven by Scer\GAL4DopEcR-GAL4, weakly suppressed by combination with Dop1R1PL00420 and not suppressed by combination with DATfmn.
The increased sensitivity of mldDTS3-1/+ heterozygote adults (reared at 18[o]C during development and transferred to 29[o]C after eclosion) to ethanol-induced sedation is fully suppressed by combination with DopEcRGAL4 in homozygous state. The double mutants display increased resistance to ethanol sedation which is comparable to that seen in DopEcRGAL4 mutants alone.